medigraphic.com
ISSN 1029-3019 (Electronic)

2012, Number 06

<< Back Next >>

MediSan 2012; 16 (06)

Therapeutical effectiveness and efficacy of the thrombolysis in Venezuelan patients with acute myocardial infarction

Planas MA, Rodríguez PCM

Language: Spanish
References: 20
Page: 847-853
PDF size: 173.61 Kb.


ABSTRACT

A descriptive and observational study was carried out in 24 patients with clinical, electrocardiographic and enzymatic signs of acute myocardial infarction, in whom thrombolytic therapy was administered (recombinant streptokinase), attended in the Intensive Care Unit of Socorro health area, belonging to Valencia municipality in Carabobo state (Bolivarian Republic of Venezuela), from May 2009 to May 2010, with the purpose of evaluating the impact of this therapy. There was predominance of male sex (58.3 %), age group of 50 to 59 years (45.8 %), those that received treatment before 3 hours (58.4 %), hypotension as the most common complication (66.6 %), and diaphragmatic topography (41.7 %) in the case material. The effectiveness and efficacy of the thrombolysis was confirmed, because it allows to recover ischemic areas and thereby to increase the survival of those patients.


REFERENCES

  1. Afilalo J, Majdan AA, Eisenberg MJ. Intensive statin therapy in acute coronary syndromes and stable coronary heart disease: a comparative metanalysis of randomised controlled trials. Heart. 2007; 93(8): 914–21

  2. Jorna Calixto AR, Véliz Martínez PL, Cuéllar Álvarez R. Infarto agudo del miocardio en los centros diagnósticos integrales de Vargas, Venezuela. Rev Cubana Med Gen Integr. 2010[citado 22 Feb 2012]; 26(4). Disponible en: http://www.bvs.sld.cu/revistas/mgi/vol_26_4_10/mgi14410.htm

  3. Castillo López B, Campusano Valdés A, Hernández Pedroso W. Trombolisis: aplicación, posibilidad e inconvenientes. Rev Cubana Med Int Emerg. 2007; 6(3): 768-78.

  4. Herlitz J, Hartford M, Aune S, Karlsson T, Hjalmarson A. Delay time between onset of myocardial infarction and start of thrombolysis in relation to prognosis. Cardiology. 1993; 82(5):347-53.

  5. Arós F, Cuñat J, Loma-Osorio A, Torrado E, Bosch X. Tratamiento del infarto agudo de miocardio en España en el año 2000. El estudio PRÍAMHO II. Rev Esp Cardiol. 2003 [citado 22 Feb 2012]; 56(3):1165-73. Disponible en: http://www.secardiologia.es/images/stories/file/cardiopatia-isquemica/descriptivo_general.pdf

  6. Mercé J, Lindon RM, Escude T, Gallont E. Trombolisis en el infarto agudo del miocardio en la práctica clínica. Estudio prospectivo en un hospital terciario. Rev Esp Cardiol. 1996; 49(3):112-6.

  7. Cabadés A, Echanove I, Cardona J, Valls F, Parra V. Características, manejo y pronóstico del paciente con Infarto Agudo del Miocardio en la Comunidad Valenciana en 2005: resultados del registro PRIMVAC (Proyecto de Registro de Infarto Agudo de Miocardio de Valencia, Alicante y Castellón). Rev Esp Cardiol. 1999; 52:123-33.

  8. Cabadés O´Callaghan A. El registro REGICOR y la epidemiología del infarto de miocardio en España: se hace camino al andar. Rev Esp Cardiol. 2007; 60 (4):342-5.

  9. Duchateau FX, Devaud ML, Burnod A, Mantz J, Ricard Hubon A. A quality control programme for acute myocardial infarction management in out of hospital critical care medicine. Emerg Med J. 2007; 24 (7):487-8.

  10. Topol EJ. Thrombolytic therapy in acute myocardial infarction. En: Agnelli G. Thrombolysis Yearbook. Amsterdam: Excerpta Médica; 1995. p. 55-101.

  11. Ford ES, Ajani UA, Croft JB, Critchley JA, Labarthe DR, Kottke TE, et al. Explaining the decrease in U.S. deaths from coronary disease, 1980-2000. N Engl J Med. 2007; 356:2388-98.

  12. Gil M, Martí H, Elosúa R, Grau M, Sala J, Masiá R, et al. Análisis de la tendencia en la letalidad, incidencia y mortalidad por infarto de miocardio en Girona entre 1990 y 1999. Rev Esp Cardiol. 2007; 60 (4): 349-56.

  13. Steg PG, López Sendón J, López de Sa E, Goodman SG, Gore JM, Anderson FA, et al. External validity of clinical trials in acute myocardial infarction. Arch Intern Med. 2007; 167(1):68-73.

  14. EBM Guidelines. Evidence-Based Medicine. 10th. Madrid: John Wiley and Sons; 2005.

  15. Scottish Intercollegiate Guidelines Networtl (SIGN). Acute coronary syndromes. Edinburg: SIGN (publication no.94); 2007.

  16. Van de Werf F, Bax J, Betriu A, Blomstrom Lundqvist C, Crea F, Falk V, et al. Acute myocardial infarction in patients presenting with ST-segment elevation (Management of). Eur Heart J. 2008; 29: 2909-45.

  17. Fox KA, Birkhead J, Wilcox R, Knight C, Barth J. British Cardiac Society Group on the definition of myocardial infarction. Heart 2004; 90(6):603-9.

  18. Scottish Intercollegiate Guidelines Networtl. Risk estimation and the prevention of cardiovascular disease. Edinburg: SIGN (publication no.97); 2007.

  19. ST-elevation myocardial infarction Guidelines Group; New Zealand Branch of the Cardiac Society of Australia and New Zealand. ST-elevation myocardial infarction: New Zealand management guidelines. N Z Med J. 2005; 118(1223):U1679.

  20. Rodríguez Gómez R, López de Castro García O, Jiménez Rafuls L, Gómez Maciñeira I, Castellano Becerril F. Infarto agudo del miocardio. Estudio de un año. Facultad de Ciencias Médicas "Dr. Faustino Pérez Hernández". Gaceta Médica Espirituana. 2007 [citado 22 Feb 2012]; 9 (1). Disponible en:http://bvs.sld.cu/revistas/gme/pub/vol.9.(1)_05/p5.html




2020     |     www.medigraphic.com